非奈利酮与SGLT2抑制剂对2型糖尿病和/或慢性肾脏病患者心血管事件的影响
Effects of finerenone versus SGLT2 inhibitors on cardiovascular events in patients with type 2 diabetes mellitus and/or chronic kidney disease